Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedJun 07, 2023
DataAggregated Company Financials
Companies7
  • 7D2.0%
  • 3M-21.0%
  • 1Y-59.6%
  • YTD-25.7%

Over the last 7 days, the Biotech industry has risen 2.0%, driven by gains from Idorsia of 7.2%. In contrast, the industry has lost 60% in the last 12 months. Earnings are forecast to grow by 9.3% annually.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 07 Jun 2023CHF325.2mCHF334.1m-CHF181,188,533.00n/a-1.8x1x
Fri, 05 May 2023CHF381.0mCHF496.3m-CHF18,252,374.001.7x-20.9x0.8x
Sun, 02 Apr 2023CHF428.2mCHF497.3mCHF12.3m1.5x34.8x0.9x
Tue, 28 Feb 2023CHF490.4mCHF493.4mCHF14.5m1.6x33.8x1x
Thu, 26 Jan 2023CHF511.5mCHF493.4mCHF14.5m1.7x35.3x1x
Sat, 24 Dec 2022CHF501.6mCHF493.4mCHF14.5m1.7x34.6x1x
Mon, 21 Nov 2022CHF515.5mCHF494.8mCHF14.5m1.8x35.6x1x
Wed, 19 Oct 2022CHF509.7mCHF510.1mCHF15.9m1.9x32.1x1x
Fri, 16 Sep 2022CHF529.0mCHF495.8mCHF27.8m1.9x19x1.1x
Sun, 14 Aug 2022CHF527.5mCHF482.7mCHF38.7m1.9x13.6x1.1x
Tue, 12 Jul 2022CHF585.5mCHF460.6mCHF81.6m2.2x7.2x1.3x
Thu, 09 Jun 2022CHF626.5mCHF470.6mCHF25.0m2.1x25x1.3x
Sat, 07 May 2022CHF721.2mCHF301.5m-CHF144,267,932.001.9x-5x2.4x
Mon, 04 Apr 2022CHF1.2bCHF288.4m-CHF143,186,966.002x-8.2x4.1x
Wed, 02 Mar 2022CHF1.3bCHF281.4m-CHF139,079,671.002x-9.5x4.7x
Fri, 28 Jan 2022CHF5.2bCHF320.6m-CHF658,577,634.001.5x-7.9x16.3x
Sun, 26 Dec 2021CHF4.2bCHF317.4m-CHF659,020,639.001.5x-6.3x13.2x
Tue, 23 Nov 2021CHF3.8bCHF320.3m-CHF658,611,195.001.5x-5.7x11.8x
Thu, 21 Oct 2021CHF4.7bCHF304.9m-CHF641,744,123.002.3x-7.3x15.3x
Sat, 18 Sep 2021CHF5.3bCHF302.6m-CHF612,743,058.001.3x-8.6x17.4x
Mon, 16 Aug 2021CHF5.4bCHF306.0m-CHF612,309,374.801.1x-8.8x17.6x
Mon, 31 May 2021CHF5.8bCHF352.3m-CHF535,605,963.801.1x-10.8x16.4x
Thu, 04 Mar 2021CHF6.2bCHF407.2m-CHF561,055,198.506x-11.1x15.3x
Sun, 06 Dec 2020CHF6.5bCHF399.6m-CHF565,530,866.507.1x-11.5x16.3x
Wed, 09 Sep 2020CHF6.0bCHF393.6m-CHF565,357,804.50496.9x-10.6x15.2x
Price to Earnings Ratio

-8.7x


Total Market Cap: CHF4.9bTotal Earnings: -CHF565,357,804.50Total Revenue: CHF393.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Price to Earnings3Y Average 2.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Swiss Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.2x is higher than the industry's current PS ratio of 0.97x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 5.3% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.21%
Healthcare2.60%
Biotech1.98%
Biotech1.98%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IDIA IdorsiaCHF8.247.2%
+CHF97.9m
-45.7%PS13x
MOLN Molecular PartnersCHF6.106.5%
+CHF12.1m
-14.1%PS10.1x
SANN Santhera Pharmaceuticals HoldingCHF0.9212.7%
+CHF12.0m
-12.2%PS14.3x
KURN Kuros BiosciencesCHF1.383.4%
+CHF1.6m
-29.1%PS2.8x
SPEX SpexisCHF0.350.6%
+CHF1.1m
-66.5%PS12.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BSLN

CHF45.20

Basilea Pharmaceutica

7D

-3.1%

1Y

37.0%

RLF

CHF3.42

Relief Therapeutics Holding

7D

-15.9%

1Y

-76.5%

SPEX

CHF0.35

Spexis

7D

0.6%

1Y

-66.5%

ADXN

CHF0.12

Addex Therapeutics

7D

-2.5%

1Y

-81.7%

MOLN

CHF6.10

Molecular Partners

7D

6.5%

1Y

-14.1%

IDIA

CHF8.24

Idorsia

7D

7.2%

1Y

-45.7%

OBSN

CHF0.067

ObsEva

7D

-2.6%

1Y

-96.6%

KURN

CHF1.38

Kuros Biosciences

7D

3.4%

1Y

-29.1%